People

Sébastien Bréche is a publicly named member of Porsolt’s scientific and commercial team. Its2026 EUROTOX announcement names him as a company representative discussing preclinical neurotoxicity and histology models, including NMDA-induced Olney’s lesions. He is also a co-author of the company’s safety-pharmacology and predictive-toxicology research posters. Individual job title and fuller career biography were not verified.